Pathogenesis of Shiga-toxin producing Escherichia coli

Current Topics in Microbiology and Immunology

Volumn 357, Issue , 2012, Pages 67-103

  Melton Celsa, Angela ^a   Mohawk, Krystle ^a   Teel, Louise ^a   O'Brien, Alison ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; CHEMOKINE; CYTOKINE; FOSFOMYCIN; INTIMIN; MONOCLONAL ANTIBODY; PROTEIN TIR; TOXIN ANTIBODY; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2; VIRULENCE FACTOR;

ALLELE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM EXAMINATION; CELL DAMAGE; CELL FUNCTION; CYTOLYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE MODEL; DISEASE TRANSMISSION; ECOLOGICAL NICHE; ENDOTHELIUM CELL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPIDEMIC; ESCHERICHIA COLI INFECTION; EXPERIMENTAL ANIMAL; GENE EXPRESSION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC TRANSDUCTION; GLOMERULUS; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HOST CELL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTESTINE EPITHELIUM CELL; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PHYLOGENY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES IDENTIFICATION; STX GENE; TOXIN ANALYSIS; TYPE III SECRETION SYSTEM;

ANIMALIA; ESCHERICHIA COLI;

EID: 84857859411     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82_2011_176     Document Type: Article

References (208)

1. Abu-Ali GS, Ouellette LM, Henderson ST, Lacher DW, Riordan JT, Whittam TS, Manning SD (2010) Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS.ONE 5:e10167. doi:10.1371/journal.pone.0010167
2. Abu-Median AB, van Diemen PM, Dziva F, Vlisidou I, Wallis TS, Stevens MP (2006) Functional analysis of lymphostatin homologues in enterohaemorrhagic Escherichia coli. FEMS Microbiol Lett 258:43-49. doi:FML198[pii];10.1111/j.1574- 6968.2006.00198.x
3. Acheson DW, Moore R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E, Keusch GT (1996) Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 64:3294-3300 (Pubitemid 26256179)
4. Ahmed A, Li J, Shiloach Y, Robbins JB, Szu SC (2006) Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children. J Infect Dis 193:515-521 (Pubitemid 43202742)
5. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI (2005) Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115:e673-e680. doi:115/6/e673[pii];10.1542/peds.2004-2236 (Pubitemid 43852790)
6. Andreoli SP, Trachtman H, Acheson DW, Siegler RL, Obrig TG (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293-298
7. Asadulghani M, Ogura Y, Ooka T, Itoh T, Sawaguchi A, Iguchi A, Nakayama K, Hayashi T (2009) The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog 5:e1000408. doi:10.1371/journal.ppat.1000408
8. Ashkenazi S, Larocco M, Murray BE, Cleary TG (1992) The adherence of verocytotoxinproducing Escherichia coli to rabbit intestinal cells. J Med Microbiol 37:304-309
9. Baines D, Lee B, McAllister T (2008) Heterogeneity in enterohemorrhagic Escherichia coli O157:H7 fecal shedding in cattle is related to Escherichia coli O157:H7 colonization of the small and large intestine. Can J Microbiol 54:984-995. doi:w08-090[pii];10.1139/w08-090
10. Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG (2001) The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063-1070 (Pubitemid 32230954)
11. Beery JT, Doyle MP, Schoeni JL (1985) Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol 49:310-315 (Pubitemid 15136457)
12. Berry ED, Wells JE (2010) Escherichia coli O157:H7 Recent Advances in Research on Occurrence, Transmission, and Control in Cattle and the Production Environment. Adv Food Nutr Res 60:67-117. doi:S1043-4526(10)60004-6[pii];10. 1016/S1043-4526(10)60004-6
13. Beutin L, Montenegro MA, Orskov I, Orskov F, Prada J, Zimmermann S, Stephan R (1989) Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J Clin Microbiol 27:2559-2564 (Pubitemid 19251807)
14. Bielaszewska M, Friedrich AW, Aldick T, Schurk-Bulgrin R, Karch H (2006) Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 43:1160-1167 (Pubitemid 44632799)
15. Bielaszewska M, Stoewe F, Fruth A, Zhang W, Prager R, Brockmeyer J, Mellmann A, Karch H, Friedrich AW (2009) Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J Clin Microbiol 47:2061-2066. doi:JCM.00201-09[pii];10.1128/JCM.00201-09
16. Bitzan M, Moebius E, Ludwig K, Müller-Wiefel DE, Heesemann J, Karch H (1991) High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 119:380-385
17. Bitzan M, Poole R, Mehran M, Sicard E, Brockus C, Thuning-Roberson C, Rivière M (2009) Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers. Antimicrob Agents Chemother 53:3081-3087. doi:AAC.01661-08[pii];10.1128/AAC. 01661-08
18. Brando RJ, Miliwebsky E, Bentancor L, Deza N, Baschkier A, Ramos MV, Fernández GC, Meiss R, Rivas M, Palermo MS (2008) Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains. Clin Exp Immunol 153:297-306 (Pubitemid 351989167)
19. Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Barbieri S, Rocchi L, Arfilli V, Scavia G, Ricci F, Bontadini A, Alfieri RR, Petronini PG, Pecoraro C, Tozzi AE, Caprioli A (2010) Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J.Leukoc Biol 88:201-210. doi:jlb.0709475[pii];10.1189/jlb.0709475
20. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192:1422-1429 (Pubitemid 41401157)
21. Brown CA, Harmon BG, Zhao T, Doyle MP (1997) Experimental Escherichia coli O157:H7 carriage in calves. Appl Environ Microbiol 63:27-32 (Pubitemid 27020364)
22. Brunder W, Schmidt H, Karch H (1997) EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 24:767-778 (Pubitemid 27229722)
23. Brunder W, Schmidt H, Frosch M, Karch H (1999) The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145(Pt 5):1005-1014 (Pubitemid 29231803)
24. Calderwood SB, Mekalanos JJ (1987) Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol 169:4759-4764 (Pubitemid 18052235)
25. Caletti MG, Balestracci A, Roy AH (2010) Levels of urinary transforming growth factor b1 in children with D ? hemolytic uremic syndrome. Pediatr Nephrol 25:1177-1180. doi:10.1007/s00467-009-1434-0
26. Campellone KG, Leong JM (2003) Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr Opin Microbiol 6:82-90 (Pubitemid 36258542)
27. Centers for Disease Control, Prevention (1995) Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21-Helena, Montana, 1994 MMWR 44:501-503
28. Clark WF, Sontrop JM, Macnab JJ, Salvadori M, Moist L, Suri R, Garg AX (2010) Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study. BMJ 341:c6020
29. Conlan JW, Perry MB (1998) Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can J Microbiol 44:800-805
30. Conradi H (1903) Uber iosliche, durch asptische autolyse erhaltene Giftstoffe vonRuhr-und typhus-bazillen. Dtsch Med Wochenschr 29:26-28
31. Cornick NA, Matise I, Samuel JE, Bosworth BT, Moon HW (2000) Shiga toxin-producing Escherichia coli infection: temporal and quantitative relationships among colonization, toxin production, and systemic disease. J Infect Dis 181:242-251. doi:JID990309[pii];10.1086/315172 (Pubitemid 30049055)
32. Cornick NA, Booher SL, Moon HW (2002) Intimin facilitates colonization by Escherichia coli O157:H7 in adult ruminants. Infect Immun 70:2704-2707 (Pubitemid 34408420)
33. Cray WC Jr, Moon HW (1995) Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl Environ Microbiol 61:1586-1590
34. Currie CG, McCallum K, Poxton IR (2001) Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J Med Microbiol 50:345-354 (Pubitemid 32239019)
35. CDC( 2005) Outbreaks of Escherichia coli O157:H7 associated with petting zoos-North Carolina, Florida, and Arizona, 2004 and 2005. MMW, 54,1277-1280.
36. Deacon V, Dziva F, van Diemen PM, Frankel G, Stevens MP (2010) Efa-1/LifA mediates intestinal colonization of calves by enterohaemorrhagic Escherichia coli O26 : H-in a manner independent of glycosyltransferase and cysteine protease motifs or effects on type III secretion. Microbiology 156:2527-2536. doi:mic.0.039685-0[pii];10.1099/mic.0.039685-0
37. Dean-Nystrom EA, Bosworth BT, Cray WC Jr, Moon HW (1997) Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 65:1842-1848 (Pubitemid 27193609)
38. Dean-Nystrom EA, Bosworth BT, Moon HW, O'Brien AD (1998) Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun 66:4560-4563 (Pubitemid 28402745)
39. Dean-Nystrom EA, Bosworth BT, Moon HW (1999) Pathogenesis of Escherichia coli O157:H7 in weaned calves. Adv Exp Med Biol 473:173-177
40. Dong T, Schellhorn HE (2009) Global effect of RpoS on gene expression in pathogenic Escherichia coli O157:H7 strain EDL933 BMC. Genomics 10:349. doi:1471-2164-10-349[pii];10.1186/1471-2164-10-349
41. Dowling TC, Chavaillaz PA, Young DG, Melton-Celsa A, O'Brien A, Thuning-Roberson C, Edelman R, Tacket CO (2005) Phase 1 safety and pharmacokinetic study of chimeric murinehuman monoclonal antibody caStx2 administered intravenously to healthy adult volunteers. Antimicrob Agents Chemother 49:1808-1812 (Pubitemid 40631593)
42. Dziva F, Mahajan A, Cameron P, Currie C, McKendrick IJ, Wallis TS, Smith DG, Stevens MP (2007) EspP, a Type V-secreted serine protease of enterohaemorrhagic Escherichia coli O157:H7, influences intestinal colonization of calves and adherence to bovine primary intestinal epithelial cells FEMS. Microbiol Lett 271:258-264. doi:FML724[pii];10.1111/j.1574-6968.2007.00724.x (Pubitemid 46802174)
43. Edwards AC, Melton-Celsa AR, Arbuthnott K, Stinson JR, Schmitt CK, Wong HC, O'Brien AD (1998) Vero cell neutralization and mouse protective efficacy of humanized monoclonal antibodies against Escherichia coli toxins Stx1 and Stx2. In: Kaper JB, O'Brien AD (eds) Escherichia coli O157:H7 and other Shiga toxin-producing E coli strains. ASM Press, Washington, DC, pp 388-392
44. Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 262:5908-5912
45. Farmer JJ III, Potter ME, Riley LW, Barrett TJ, Blake PA, Bopp CA, Cohen ML, Kaufmann A, Morris GK, Remis RS, Thomason BM, Wells JG (1983) Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis. Lancet 1:702-703 (Pubitemid 13158438)
46. Fegan N, Desmarchelier P (2002) Comparison between human and animal isolates of Shiga toxin-producing Escherichia coli O157 from Australia. Epidemiol Infect 128:357-362 (Pubitemid 34716362)
47. Feng P, Lampel KA, Karch H, Whittam TS (1998) Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis 177:1750-1753 (Pubitemid 28243610)
48. Fenwick BW, Cowan LA (1998) Canine model of the hemolytic uremic syndrome. In: Kaper JB, O'Brien AD (eds) Escherichia coli O157:H7 and other Shiga toxin-producing E coli. ASM Press, Washington, DC, pp 268-277
49. Ferens WA, Hovde CJ (2010) Escherichia coli O157:H7: animal reservoir and sources of human infection. Foodborne Pathog Dis. doi:10.1089/fpd.2010.0673
50. Fontaine A, Arondel J, Sansonetti PJ (1988) Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox-mutant of Shigella dysenteriae 1. Infect Immun 56:3099-3109
51. Foster JW (2004) Escherichia coli acid resistance: tales of an amateur acidophile. Nat Rev Microbiol 2:898-907. doi:nrmicro1021[pii];10.1038/ nrmicro1021 (Pubitemid 39561806)
52. Francis DH, Collins JE, Duimstra JR (1986) Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis. Infect Immun 51:953-956 (Pubitemid 16163002)
53. Fratamico PM, Bhaduri S, Buchanan RL (1993) Studies on Escherichia coli serotype O157:H7 strains containing a 60-MDa plasmid and on 60-MDa plasmid-cured derivatives. J Med Microbiol 39:371-381 (Pubitemid 23356043)
54. Fratamico PM, Yan X, Caprioli A, Esposito G, Needleman DS, Pepe T, Tozzoli R, Cortesi ML, Morabito S (2011) The complete DNA sequence and analysis of the virulence plasmid and of five additional plasmids carried by Shiga toxin-producing Escherichia coli O26:H11 strain H30. Int J Med Microbiol 301:192-203. doi:S1438-4221(10)00105-0[pii];10.1016/j.ijmm.2010.09.002
55. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185:74-84. doi:JID010725[pii] ;10.1086/338115 (Pubitemid 34043019)
56. Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu JG, Tschäpe H, Karch H (2006) Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiols 44:1844-1846. doi:44/5/1844[pii];10.1128/JCM.44.5.1844-1846.2006 (Pubitemid 43726280)
57. Fuchs S, Muhldorfer I, Donohue-Rolfe A, Kerenyi M, Emody L, Alexiev R, Nenkov P, Hacker J (1999) Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog 27:13-23 (Pubitemid 29366441)
58. Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y (1994) Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H-in mitomycin-treated mice. Infect Immun 62:3447-3453 (Pubitemid 24232132)
59. Gao X, Wan F, Mateo K, Callegari E, Wang D, Deng W, Puente J, Li F, Chaussee MS, Finlay BB, Lenardo MJ, Hardwidge PR (2009) Bacterial effector binding to ribosomal protein S3 subverts NF-jB function. PLoS Pathog 5:e1000708. doi:10.1371/journal.ppat.1000708
60. Garcia A, Marini RP, Feng Y, Vitsky A, Knox KA, Taylor NS, Schauer DB, Fox JG (2002) A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease. J Infect Dis 186:1682-1686 (Pubitemid 35379649)
61. Garcia A, Bosques CJ, Wishnok JS, Feng Y, Karalius BJ, Butterton JR, Schauer DB, Rogers AB, Fox JG (2006) Renal injury is a consistent finding in Dutch belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis 193:1125-1134
62. García A, Marini RP, Catalfamo JL, Knox KA, Schauer DB, Rogers AB, Fox JG (2008) Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch belted rabbits. Microbes Infect 10:650-656. doi:S1286-4579(08)00084-1[pii] ;10.1016/j.micinf.2008.03.004
63. Garmendia J, Carlier MF, Egile C, Didry D, Frankel G (2006) Characterization of TccP-mediated N-WASP activation during enterohaemorrhagic Escherichia coli infection. Cell Microbiol 8:1444-1455 (Pubitemid 44194577)
64. Glantz PJ, Gyles CL, Greenfield J, Øtskov F (1973) Isolation of Escherichia coli O157 from pigs with colibacillosis in Canada and the United States. Can J Comp Med 37:200-202
65. Gobert AP, Coste A, Guzman CA, Vareille M, Hindré T, de S.T, Girardeau JP, Martin C (2008) Modulation of chemokine gene expression by Shiga-toxin producing Escherichia coli belonging to various origins and serotypes. Microbes Infect 10:159-165. doi:S1286-4579(07)00339-5[pii];10.1016/j. micinf.2007.10.018
66. Golan L, Gonen E, Yagel S, Rosenshine I, Shpigel NY (2011) Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models. Dis Model Mech 4:86-94. doi:dmm.005777[pii];10.1242/dmm.005777
67. Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, Smith K, Shiferaw B, Segler S, Palmer A, Zansky S, Griffin PM (2009) Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 49:1480-1485. doi:10.1086/644621
68. Grauke LJ, Kudva IT, Yoon JW, Hunt CW, Williams CJ, Hovde CJ (2002) Gastrointestinal tract location of Escherichia coli O157:H7 in ruminants. Appl Environ Microbiol 68:2269-2277 (Pubitemid 34477821)
69. Grys TE, Siegel MB, Lathem WW, Welch RA (2005) The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect Immun 73:1295-1303 (Pubitemid 40470714)
70. Habdas BJ, Smart J, Kaper JB, Sperandio V (2010) The LysR-type transcriptional regulator QseD alters type three secretion in enterohemorrhagic Escherichia coli and motility in K-12 Escherichia coli. J Bacteriol 192:3699-3712. doi:JB.00382-10[pii];10.1128/JB.00382-10
71. Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, Han CG, Ohtsubo E, Nakayama K, Murata T, Tanaka M, Tobe T, Iida T, Takami H, Honda T, Sasakawa C, Ogasawara N, Yasunaga T, Kuhara S, Shiba T, Hattori M, Shinagawa H (2001) Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 8:11-22 (Pubitemid 33617542)
72. Hedican EB, Medus C, Besser JM, Juni BA, Koziol B, Taylor C, Smith KE (2009) Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis 49:358-364. doi:10.1086/600302
73. Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, MacDonald TT, Frankel G (2008) Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76:4804-4813. doi:IAI.00742-08[pii];10.1128/IAI.00742-08
74. Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci USA 107:3129-3134. doi:0911609106[pii];10.1073/pnas.0911609106
75. Hermos CR, Janineh M, Han LL, McAdam AJ (2010) Shiga toxin-producing Escherichia coli in children: detection and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. doi:JCM.02119-10[pii];10.1128/JCM. 02119-10
76. Herold S, Paton JC, Paton AW (2009) Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formation. Infect Immun 77:3234-3243. doi:IAI.00031-09[pii];10.1128/IAI.00031-09
77. Ho TD, Davis BM, Ritchie JM, Waldor MK (2008) Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization. Infect Immun 76:1858-1865 (Pubitemid 351656119)
78. Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DW (1999) Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun 67:6670-6677
79. Hussein HS (2007) Prevalence and pathogenicity of Shiga toxin-producing Escherichia coli in beef cattle and their products. J Anim Sci 85:E63-E72. doi:jas.2006-421[pii];10.2527/jas.2006-421
80. Ichinohe N, Ohara-Nemoto Y, Nemoto TK, Kimura S, Ichinohe S (2009) Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxinencoding genes and their expression levels using real-time PCR. J Med Microbiol 58:971-973. doi:jmm.0.008573-0[pii];10.1099/jmm. 0.008573-0
81. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K (1999) Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Clin Nephrol 52:357-362
82. Isogai E, Isogai H, Kimura K, Hayashi S, Kubota T, Fujii N, Takeshi K (1998) Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 66:197-202 (Pubitemid 28018820)
83. Ito H, Terai A, Kurazono H, Takeda Y, Nishibuchi M (1990) Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome. Microb Pathog 8:47-60 (Pubitemid 20222891)
84. Jacewicz M, Clausen H, Nudelman E, Donohue-Rolfe A, Keusch GT (1986) Pathogenesis of Shigella diarrhea XI. Isolation of a Shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163:1391-1404 (Pubitemid 16043460)
85. Janka A, Bielaszewska M, Dobrindt U, Greune L, Schmidt MA, Karch H (2003) Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H-and O157:H7: characterization and evolutionary considerations. Infect Immun 71:3634-3638 (Pubitemid 36637596)
86. Jeong KI, Tzipori S, Sheoran AS (2010) Shiga toxin 2-specific but not Shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing Shiga toxin 1 and Shiga toxin 2. J Infect Dis 201:1081-1083. doi:10.1086/651198
87. Jerse AE, Yu J, Tall BD, Kaper JB (1990) A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87:7839-7843
88. Johansen BK, Wasteson Y, Granum PE, Brynestad S (2001) Mosaic structure of Shiga-toxin-2-encoding phages isolated from Escherichia coli O157:H7 indicates frequent gene exchange between lambdoid phage genomes. Microbiology 147:1929-1936 (Pubitemid 32684934)
89. Judge NA, Mason HS, O'Brien AD (2004) Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect Immun 72:168-175 (Pubitemid 38018174)
90. Kaneko K, Kiyokawa N, Ohtomo Y, Nagaoka R, Yamashiro Y, Taguchi T, Mori T, Fujimoto J, Takeda T (2001) Apoptosis of renal tubular cells in Shiga-toxin-mediated hemolytic uremic syndrome. Nephron 87:182-185 (Pubitemid 32215832)
91. Kang G, Pulimood AB, Koshi R, Hull A, Acheson D, Rajan P, Keusch GT, Mathan VI, Mathan MM (2001) A monkey model for enterohemorrhagic Escherichia coli infection. J Infect Dis 184:206-210 (Pubitemid 32614052)
92. Käppeli U, Hächler H, Giezendanner N, Cheasty T, Stephan R (2010) Shiga toxin-producing Escherichia coli O157 associated with human infections in Switzerland, 2000-2009. Epidemiol Infect:1-8. doi: S0950268810002190[pii];10.1017/S0950268810002190
93. Karch H, Bielaszewska M (2001) Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H-strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J Clin Microbiol 39:2043-2049. doi:10.1128/JCM.39.6.2043-2049.2001 (Pubitemid 32531456)
94. Karch H, Goroncy-Termes P, Opferkuch W, Kroll H-P, O'Brien A (1985) Subinhibitory concentrations of antibiotics modulate amount of Shiga-like toxin produced by Escherichia coli. In: Adam D, Hahn H, Opferkuch W (eds) The influence of antibiotics on the hostparasite relationship II. Springer, Berlin, pp 239-245
95. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB (2003) Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41:4930-4940 (Pubitemid 37429898)
96. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C (1997) The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 175:611-620 (Pubitemid 27086165)
97. Karpman D, Hakansson A, Perez MT, Isaksson C, Carlemalm E, Caprioli A, Svanborg C (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66:636-644 (Pubitemid 28074206)
98. Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD (1986) Morphologic evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. Am J Pathol 125:69-80 (Pubitemid 17183759)
99. Keepers TR, Psotka MA, Gross LK, Obrig TG (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404-3414 (Pubitemid 44865283)
100. Kendall MM, Rasko DA, Sperandio V (2010) The LysR-type regulator QseA regulates both characterized and putative virulence genes in enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 76:1306-1321. doi:MMI7174[pii];10.1111/ j.1365-2958.2010.07174.x
101. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520 (Pubitemid 27508240)
102. Kimura T, Co MS, Vasquez M, Wei S, Xu H, Tani S, Sakai Y, Kawamura T, Matsumoto Y, Nakao H, Takeda T (2002) Development of humanized monoclonal antibody TMA-15 which neutralizes Shiga toxin 2. Hybrid Hybridomics 21:161-168 (Pubitemid 35007521)
103. King T, Lucchini S, Hinton JC, Gobius K (2010) Transcriptomic analysis of Escherichia coli O157:H7 and K-12 cultures exposed to inorganic and organic acids in stationary phase reveals acidulant-and strain-specific acid tolerance responses. Appl Environ Microbiol 76:6514-6528. doi:AEM.02392-09[pii];10.1128/ AEM.02392-09
104. Kokai-Kun JF, Melton-Celsa AR, O'Brien AD (2000) Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem 275:3713-3721 (Pubitemid 30083085)
105. Konadu E, Robbins JB, Shiloach J, Bryla DA, Szu SC (1994) Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect Immun 62:5048-5054 (Pubitemid 24332814)
106. Konadu EY, Parke JC Jr, Tran HT, Bryla DA, Robbins JB, Szu SC (1998) Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults. J Infect Dis 177:383-387 (Pubitemid 28063763)
107. Konowalchuk J, Speirs JI, Stavric S (1977) Vero response to a cytotoxin of Escherichia coli. Infect Immun 18:775-779 (Pubitemid 8247697)
108. Kresse AU, Rienäcker I, Valle AM, Steinrück H, Claus H, Payne SM, Tschäpe H, Williams PH, Reissbrodt R (2007) Enterohaemorrhagic Escherichia coli O157 and non-O157 serovars differ in their mechanisms for iron supply. Int J Med Microbiol 297:9-15. doi:S1438-4221(06)00226-8[pii];10.1016/j. ijmm.2006.11.002 (Pubitemid 46149472)
109. Kurioka T, Yunou Y, Kita E (1998) Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 66:1726-1734 (Pubitemid 128471540)
110. Lariviére SR, Lallier. (1976) Escherichia coli strains isolated from diarrheic piglets in the Province of Quebec. Can J Comp Med 40:190-197
111. Ledesma MA, Ochoa SA, Cruz A, Rocha-Ramirez LM, Mas-Oliva J, Eslava CA, Girón JA, Xicohtencatl-Cortes J (2010) The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells. PLoSONE. 5:12127. doi:10.1371/journal.pone. 0012127
112. Leotta GA, Miliwebsky ES, Chinen I, Espinosa EM, Azzopardi K, Tennant SM, Robins-Browne RM, Rivas M (2008) Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol 8:46. doi:1471-2180-8-46[pii];10.1186/1471-2180-8-46 (Pubitemid 351473485)
113. Levine MM (1987) Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis 155:377-389 (Pubitemid 17032795)
114. Lim JY, Yoon J, Hovde CJ (2010) A Brief Overview of Escherichia coli O157:H7 and Its Plasmid O157. J Microbiol Biotechnol 20:5-14. doi:JMB020-01-01[pii]
115. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE, Karlsson KA (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262:1779-1785
116. Lindgren SW, Melton AR, O'Brien AD (1993) Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 61:3832-3842 (Pubitemid 23260057)
117. Lindgren SW, Samuel JE, Schmitt CK, O'Brien AD (1994) The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun 62:623-631 (Pubitemid 24033783)
118. Livny J, Friedman DI (2004) Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol 51:1691-1704. doi:3934[pii] (Pubitemid 38406542)
119. Low JC, McKendrick IJ, McKechnie C, Fenlon D, Naylor SW, Currie C, Smith DG, Allison L, Gally DL (2005) Rectal carriage of enterohemorrhagic Escherichia coli O157 in slaughtered cattle. Appl Environ Microbiol 71:93-97. doi:71/1/93[pii];10.1128/AEM.71.1.93-97.2005 (Pubitemid 40116255)
120. Makino K, Ishii K, Yasunaga T, Hattori M, Yokoyama K, Yutsudo CH, Kubota Y, Yamaichi Y, Iida T, Yamamoto K, Honda T, Han CG, Ohtsubo E, Kasamatsu M, Hayashi T, Kuhara S, Shinagawa H (1998) Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res 5:1-9 (Pubitemid 128670193)
121. Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, Ouellette LM, Mladonicky JM, Somsel P, Rudrik JT, Dietrich SE, Zhang W, Swaminathan B, Alland D, Whittam TS (2008) Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci USA 105:4868-4873 (Pubitemid 351753838)
122. McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O'Brien AD (1995) Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 63:3739-3744
123. Melton-Celsa AR, Darnell SC, O'Brien AD (1996) Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun 64:1569-1576 (Pubitemid 26129817)
124. Melton-Celsa AR, Smith MJ, O'Brien AD (2005) Shiga toxins: potent poisons, pathogenicity determinants, and pharmacological agents. In: Curtiss III R (ed) EcoSal-Escherichia coli and Salmonella: Cellular and molecular biology (Online), 2nd edn. ASM Press, Washington, D.C
125. Melton-Celsa AR, Robinson CM, Smith MJ, O'Brien AD (2007) Shiga toxins (Stxs): multifaceted pathogenicity determinants. In: Brogden KA, Minion FC, Cornick N, Stanton TB, Zhang Q, Nolan LK, Wannemuehler MJ (eds) Virulence mechanisms of bacterial pathogens, 4th edn. ASM Press, Washington, DC, pp 239-251
126. Michino H, Araki K, Minami S, Takaya S, Sakai N, Miyazaki M, Ono A, Yanagawa H (1999) Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 150:787-796 (Pubitemid 29482831)
127. Miller SI, Kukral AM, Mekalanos JJ (1989) A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci USA 86:5054-5058 (Pubitemid 19182231)
128. Mohawk KL, O'Brien AD (2011) Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J Biomed Biotechnol 2011:258185. doi:10.1155/2011/258185
129. Mohawk KL, Melton-Celsa AR, Zangari T, Carroll EE, O'Brien AD (2010) Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog 48:131-142. doi:S0882-4010(10)00014-8[pii];10.1016/j.micpath.2010.01.003
130. Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S (2002a) Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 70:612-619 (Pubitemid 34083820)
131. Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S (2002b) Production and characterization of protective human antibodies against Shiga toxin 1. Infect Immun 70:5896-5899
132. Mulvey GL, Marcato P, Kitov PI, Sadowska J, Bundle DR, Armstrong GD (2003) Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J Infect Dis 187:640-649 (Pubitemid 36250028)
133. Nagano K, Taguchi K, Hara T, Yokoyama S, Kawada K, Mori H (2003) Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol Immunol 47:125-132 (Pubitemid 36240891)
134. Naylor SW, Low JC, Besser TE, Mahajan A, Gunn GJ, Pearce MC, McKendrick IJ, Smith DG, Gally DL (2003) Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun 71:1505-1512 (Pubitemid 36254338)
135. Neisser M, Shiga K (1903) Ueber freie recptoren von Typhu-und dysenterue-bazillen und ueber das dysenterie toxin. Dtsch Med Wochenschr 29:61-62
136. Nishikawa K, Matsuoka K, Kita E, Okabe N, Mizuguchi M, Hino K, Miyazawa S, Yamasaki C, Aoki J, Takashima S, Yamakawa Y, Nishijima M, Terunuma D, Kuzuhara H, Natori Y (2002) A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxinproducing Escherichia coli O157:H7. Proc Natl Acad Sci USA 99:7669-7674 (Pubitemid 34568749)
137. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S, Obrig TG (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198:1398-1406
138. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, Tobe T, Hattori M, Hayashi T (2009) Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA 106:17939-17944. doi:0903585106[pii];10.1073/pnas. 0903585106
139. O'Reilly KM, Low JC, Denwood MJ, Gally DL, Evans J, Gunn GJ, Mellor DJ, Reid SW, Matthews L (2010) Associations between the presence of virulence determinants and the epidemiology and ecology of zoonotic Escherichia coli. Appl Environ Microbiol 76:8110-8116. doi:AEM.01343-10[pii];10.1128/AEM.01343-10
140. Panda A, Tatarov I, Melton-Celsa AR, Kolappaswamy K, Kriel EH, Petkov D, Coksaygan T, Livio S, McLeod CG, Nataro JP, O'Brien AD, DeTolla LJ (2010) Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. Comp Med 60:31-37
141. Paton AWJC, Paton. (2010) Escherichia coli subtilase cytotoxin. Toxins (Basel) 2:215-228. doi:10.3390/toxins2020215
142. Paton AW, Srimanote P, Woodrow MC, Paton JC (2001) Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shigatoxigenic Escherichia coli strains that are virulent for humans. Infect Immun 69:6999-7009 (Pubitemid 32995460)
143. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC (2004) A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 200:35-46 (Pubitemid 38924726)
144. Paton AW, Bddoe T, Thorpe CM, Whisstock JC, Wilce MCJ, Rossjohn J, Talbot UM, Paton JC (2006) AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443:548-552 (Pubitemid 44527286)
145. Perna NT, Plunkett G III, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Pósfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533 (Pubitemid 32144360)
146. Philpott DJ, Ackerley CA, Kiliaan AJ, Karmali MA, Perdue MH, Sherman PM (1997) Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am J Physiol 273:G1349-G1358
147. Pinyon RA, Paton JC, Paton AW, Botten JA, Morona R (2004) Refinement of a therapeutic shiga toxin-binding probiotic for human trials. J Infect Dis 189:1547-1555 (Pubitemid 38648281)
148. Poirier K, Faucher SP, Béland M, Brousseau R, Gannon V, Martin C, Harel J, Daigle F (2008) Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect Immun 76:4814-4822
149. Potter ME, Kaufmann AF, Thomason BM, Blake PA, Farmer JJ III (1985) Diarrhea due to Escherichia coli O157:H7 in the infant rabbit. J Infect Dis 152:1341-1343 (Pubitemid 16215617)
150. Ptashne M (2004) A Genetic Switch. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
151. Puttamreddy SN, Cornick A, Minion FC (2010) Genome-wide transposon mutagenesis reveals a role for pO157 genes in biofilm development in Escherichia coli O157:H7 EDL933. Infect Immun doi:IAI.00156-10[pii];10.1128/IAI.00156-10
152. Raife T, Friedman KD, Fenwick B (2004) Lepirudin prevents lethal effects of Shiga toxin in a canine model. Thromb Haemost 92:387-393. doi:10.1267/THRO04080387;04080387 (Pubitemid 39172320)
153. Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA (1992) Experimental verocytotoxemia in rabbits. Infect Immun 60:4154-4167
154. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308:681-685 (Pubitemid 13157770)
155. Ritchie JMMK, Waldor. (2005) The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 73:1466-1474. doi:73/3/1466[pii];10.1128/IAI.73. 3.1466-1474.2005 (Pubitemid 40470732)
156. Ritchie JM, Thorpe CM, Rogers AB, Waldor MK (2003) Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71:7129-7139 (Pubitemid 37475345)
157. Robinson CM, Sinclair JF, Smith MJ, O'Brien AD (2006) Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci USA 103:9667-9672 (Pubitemid 43955882)
158. Sargeant JM, Amezcua, Rajic A, Waddell L (2007) Pre-harvest interventions to reduce the shedding of E. coli O157 in the faeces of weaned domestic ruminants: a systematic review. Zoonoses Public Health 54:260-277. doi:JVB1059[pii];10.1111/j.1863-2378.2007.01059.x (Pubitemid 47351519)
159. Sauter KA, Melton-Celsa AR, Larkin K, Troxell ML, O'Brien AD, Magun BE (2008) Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect Immun 76:4469-4478
160. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM (2011) Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 17:7-15
161. Schmitt CK, McKee ML, O'Brien AD (1991) Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H-strain E32511. Infect Immun 59:1065-1073
162. Serna AEC, Boedeker. (2008) Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24:38-47 (Pubitemid 350190896)
163. Sheng H, Lim JY, Knecht HJ, Li J, Hovde CJ (2006) Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect Immun 74:4685-4693 (Pubitemid 44157256)
164. Sinclair JF, O'Brien AD (2002) Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J Biol Chem 277:2876-2885 (Pubitemid 34953321)
165. Sjogren R, Neill R, Rachmilewitz D, Fritz D, Newland J, Sharpnack D, Colleton C, Fondacaro J, Gemski P, Boedeker E (1994) Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 106:306-317
166. Smith DR, Moxley RA, Peterson RE, Klopfenstein TJ, Erickson GE, Bretschneider G, Berberov EM, Clowser S (2009) A two-dose regimen of a vaccine against type III secreted proteins reduced Escherichia coli O157:H7 colonization of the terminal rectum in beef cattle in commercial feedlots. Foodborne Pathog Dis 6:155-161. doi:10.1089/fpd.2008.0136
167. Sugatani J, Komiyama N, Mochizuki T, Hoshino M, Miyamoto D, Igarashi T, Hoshi S, Miwa M (2002) Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with polyuria. Life Sci 71:171-189. doi:S0024320502016181[pii] (Pubitemid 34595436)
168. Suri, RS, Mahon JL, Clark WF, Moist LM, Salvadori M, Garg AX (2009) Relationship between Escherichia coli O157:H7 and diabetes mellitus. Kidney Int Suppl S44-S46. doi:ki2008619 [pii];10.1038/ki.2008.619
169. Tarr PI, Bilge SS, Vary JC Jr, Jelacic S, Habeeb RL, Ward TR, Baylor MR, Besser TE (2000) Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun 68:1400-1407 (Pubitemid 30108537)
170. Tatsuno I, Horie M, Abe H, Miki T, Makino K, Shinagawa H, Taguchi H, Kamiya S, Hayashi T, Sasakawa C (2001) toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect Immun 69:6660-6669 (Pubitemid 32995421)
171. Taylor CM, Williams JM, Lote CJ, Howie AJ, Thewles A, Wood JA, Milford DV, Raafat F, Chant I, Rose PE (1999a) A laboratory model of toxin-induced hemolytic uremic syndrome. Kidney Int 55:1367-1374 (Pubitemid 29157135)
172. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL (1999b) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285-1299 (Pubitemid 29169762)
173. te Loo DM, Monnens LA, van Den LP, Heuvel MC, Gubler MM, Kockx (2001) Detection of apoptosis in kidney biopsies of patients with D ? hemolytic uremic syndrome. Pediatr Res 49:413-416 (Pubitemid 32205242)
174. Teel LD, Melton-Celsa AR, Schmitt CK, O'Brien AD (2002) One of two copies of the gene for the activatable Shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage. Infect Immun 70:4282-4291 (Pubitemid 34790937)
175. Tesh VL (2010) Induction of apoptosis by Shiga toxins. Future Microbiol 5:431-453. doi:10.2217/fmb.10.4
176. Teunis P, Ogden FID, Strachan NJ (2008) Hierarchical dose response of E. coli O157:H7 from human outbreaks incorporating heterogeneity in exposure. Epidemiol Infect 136:761-770. doi:S0950268807008771[pii];10.1017/ S0950268807008771 (Pubitemid 351524011)
177. Thomson DU, Loneragan GH, Thornton AB, Lechtenberg KF, Emery DA, Burkhardt DT, Nagaraja TG (2009) Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle. Foodborne Pathog Dis 6:871-877. doi:10.1089/fpd.2009.0290
178. Tilden J Jr, Young W, McNamara AM, Custer C, Boesel B, Lambert-Fair MA, Majkowski J, Vugia D, Werner SB, Hollingsworth J, Morris JG Jr (1996) A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 86: 1142-1145 (Pubitemid 26271542)
179. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, Younis R, Matthews S, Marches O, Frankel G, Hayashi T, Pallen MJ (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 103:14941-14946 (Pubitemid 44527833)
180. Toma C, Martinez EE, Song T, Miliwebsky E, Chinen I, Iyoda S, Iwanaga M, Rivas M (2004) Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J Clin Microbiol 42:4937-4946. doi:42/11/4937[pii];10.1128/JCM.42.11.4937-4946.2004 (Pubitemid 39506192)
181. Torres AG, Zhou X, Kaper JB (2005) Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 73:18-29 (Pubitemid 40041093)
182. Toth I, Cohen ML, Rumschlag HS, Riley LW, White EH, Carr JH, Bond WW, Wachsmuth IK (1990) Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun 58:1223-1231 (Pubitemid 20151781)
183. Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DW, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH (2003) Effect of an oral Shiga toxin-binding agent on diarrheaassociated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290:1337-1344 (Pubitemid 37442630)
184. Tree JJ, Wolfson EB, Wang D, Roe AJ, Gally DL (2009) Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol 17:361-370. doi:S0966-842X(09)00128-0[pii];10.1016/j.tim. 2009.06.001
185. Tyler JS, Mills MJ, Friedman DI (2004) The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933 W and control of toxin expression. J Bacteriol 186:7670-7679. doi:186/22/7670[pii];10.1128/JB. 186.22.7670-7679.2004 (Pubitemid 39463733)
186. Tzipori S, Wachsmuth IK, Chapman C, Birden R, Brittingham J, Jackson C, Hogg J (1986) The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis 154:712-716 (Pubitemid 16032426)
187. Tzipori S, Wachsmuth KI, Smithers J, Jackson C (1988) Studies in gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from patients with hemorrhagic colitis. Gastroenterology 94:590-597 (Pubitemid 18073517)
188. Tzipori S, Gibson R, Montanaro J (1989) Nature and distribution of mucosal lesions associated with enteropathogenic and enterohemorrhagic Escherichia coli in piglets and the role of plasmid-mediated factors. Infect Immun 57:1142-1150 (Pubitemid 19087860)
189. Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H (2004) Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 17:926-941 (Pubitemid 39372524)
190. Uchida H, Kiyokawa N, Horie H, Fujimoto J, Takeda T (1999) The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 45:133-137 (Pubitemid 29016787)
191. Unkmeir AH, Schmidt (2000) Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun 68:4856-4864
192. Vingadassalom D, Campellone KG, Brady MJ, Skehan B, Battle SE, Robbins D, Kapoor A, Hecht G, Snapper SB, Leong JM (2010) Enterohemorrhagic E coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog 6:1-16. doi:10.1371/journal.ppat.1001056
193. Wadolkowski EA, Burris JA, O'Brien AD (1990a) Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58:2438-2445 (Pubitemid 20228222)
194. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD (1990b) Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shigalike toxin type II. Infect Immun 58:3959-3965
195. Wagner PL, Livny J, Neely MN, Acheson DW, Friedman DI, Waldor MK (2002) Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 44:957-970 (Pubitemid 34535532)
196. Walters MV, Sperandio (2006) Quorum sensing in Escherichia coli and Salmonella. Int J Med Microbiol 296:125-131. doi:S1438-4221(06)00042-7[pii];10. 1016/j.ijmm.2006.01.041 (Pubitemid 43375995)
197. Wang H, Paton JC, Paton AW (2007) Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J Infect Dis 196:1093-1101 (Pubitemid 47580306)
198. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, Morris GK (1983) Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol 18:512-520 (Pubitemid 13050570)
199. Whittam TS, Wachsmuth IK, Wilson RA (1988) Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 157:1124-1133
200. Woods JB, Schmitt CK, Darnell SC, Meysick KC, O'Brien AD (2002) Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis 185:550-554 (Pubitemid 34142819)
201. Yamagami S, Motoki M, Kimura T, Izumi H, Takeda T, Katsuura Y, Matsumoto Y (2001) Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J Infect Dis 184:738-742 (Pubitemid 32826425)
202. Yamamoto ET, Mizuno M, Nishikawa K, Miyazawa S, Zhang L, Matsuo S, Natori Y (2005) Shiga toxin 1 causes direct renal injury in rats. Infect Immun 73:7099-7106 (Pubitemid 41587606)
203. Yen, H, Ooka T, Iguchi A, Hayashi T, Sugimoto N, Tobe T (2010) NleC, a type III secretion protease, compromises NF-jB activation by targeting p65/RelA. PLoS Pathog 6:e1001231. doi:10.1371/journal.ppat.1001231
204. Yin X, Chambers JR, Wheatcroft R, Johnson RP, Zhu J, Liu B, Gyles CL (2009) Adherence of Escherichia coli O157:H7 mutants in vitro and in ligated pig intestines. Appl Environ Microbiol 75:4975-4983. doi:AEM.00297-09[pii];10.1128/ AEM.00297-09
205. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW (2000) Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181:664-670 (Pubitemid 30131837)
206. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282-289. doi:nm1720 [pii];10.1038/nm1720 (Pubitemid 351347912)
207. Zoja C, Buelli S, Morigi M (2010) Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 25:2231-2240. doi:10.1007/s00467-010-1522-1
208. Zotta E, Lago N, Ochoa F, Repetto HA, Ibarra C (2008) Development of an experimental hemolytic uremic syndrome in rats. Pediatr Nephrol 23:559-567